Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/2510
Title: Effect of rebagit on gastric mucosa in patients with nsaid gastropathy
Authors: Musaeva L. J., Akbarova D.S., Pulatova N.I., Saifieva N.H.
Keywords: Effect of rebagit on gastric mucosa, patients with nsaid gastropathy
Issue Date: 2022
Publisher: Toshkent
Abstract: The study involved 72 patients aged 20-65 years. Patients of the first group -35 patients received antisecretory therapy: pantoprazole 40 mg x 1 time daily during 14 days. Patients of the second group -37 people, against the background of pantoprazole 40 mg x once a day for 14 days received rebagit 100 mg 3 times a day. The criteria for selection to both groups were the presence of erosive changes of gastric mucosa and fresh ulcers on endoscopic examination
URI: http://repository.tma.uz/xmlui/handle/1/2510
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
1.pdfEffect of rebagit on gastric mucosa in patients with nsaid gastropathy199.62 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.